Diagnostic conclusions from the EASI-derived 12-lead electrocardiogram as compared with the standard 12-lead electrocardiogram in children - 17/08/11
, Dirk Q. Feild, MA b, Jerome Liebman, MD c, Charles Maynard, PhD d, Galen S. Wagner, MD e, Göran Wettrell, MD, PhD f, Olle Pahlm, MD, PhD aRésumé |
Background |
Fewer electrodes on more easily located places would facilitate electrocardiogram (ECG) recording. To investigate the possibility of simplifying ECG recording in children, we compared the diagnostic conclusions when interpreting standard versus EASI-derived 12-lead ECGs. Our hypothesis was that the variation of the interpretation of standard versus EASI-derived 12-lead ECGs was not greater than the intrareader variation of the interpretation of standard ECGs.
Methods |
The study included 221 children. The 2 lead systems were recorded simultaneously. Two experienced pediatric cardiologists interpreted the ECGs. First, the reader interpreted a set of 221 ECGs with randomly allocated standard and EASI-derived 12-lead ECGs. Next, the reader interpreted the complementary ECG set without having access to the first set. Finally, the reader reinterpreted the standard ECGs from 98 children.
Results |
The variation of the interpretation of standard versus EASI-derived 12-lead ECGs was only slightly larger than the intrareader variation of the interpretation of standard ECGs.
Conclusions |
For most of the electrocardiographic diagnoses, the conclusions from EASI-derived 12-lead ECGs were similar to those from standard ECGs. These findings support the suggestion that the EASI lead system is a potential alternative to the standard ECG in children.
Le texte complet de cet article est disponible en PDF.Plan
| This study was supported by Philips Medical Systems (Oxnard, CA). |
Vol 151 - N° 5
P. 1059-1064 - mai 2006 Retour au numéro
Article précédent
- Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy : The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study
- Giuseppe Boriani, Cord Paul Müller, Karl Heinz Seidl, Rainer Grove, Jürgen Vogt, Wilfried Danschel, Andreas Schuchert, Pierre Djiane, Mauro Biffi, Thorsten Becker, Christophe Bailleul, Hans Joachim Trappe, for the Resynchronization for the HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) investigators
- Comparison of long-term mortality across the spectrum of acute coronary syndromes
- Larry A. Allen, Christopher J. O'Donnell, Carlos A. Camargo, Robert P. Giugliano, Donald M. Lloyd-Jones
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?